Jacobson Pharma Corporation Ltd banner
J

Jacobson Pharma Corporation Ltd
HKEX:2633

Watchlist Manager
Jacobson Pharma Corporation Ltd
HKEX:2633
Watchlist
Price: 1.25 HKD -0.79% Market Closed
Market Cap: HK$2.5B

Income Statement

Earnings Waterfall
Jacobson Pharma Corporation Ltd

Income Statement
Jacobson Pharma Corporation Ltd

Rotate your device to view
Income Statement
Currency: HKD
Mar-2017 Sep-2017 Mar-2018 Sep-2018 Mar-2019 Sep-2019 Mar-2020 Sep-2020 Mar-2021 Sep-2021 Dec-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023 Mar-2024 Sep-2024 Mar-2025 Sep-2025
Revenue
Interest Expense
14
26
46
65
66
130
55
16
30
27
0
26
32
61
89
79
52
41
0
Revenue
1 256
N/A
1 424
+13%
1 549
+9%
1 622
+5%
1 478
-9%
2 235
+51%
1 571
-30%
2 267
+44%
1 446
-36%
1 501
+4%
1 923
+28%
1 596
-17%
1 850
+16%
1 268
-31%
1 401
+10%
1 468
+5%
1 563
+6%
1 577
+1%
1 533
-3%
Gross Profit
Cost of Revenue
(699)
(832)
(931)
(964)
(803)
(1 210)
(881)
(1 311)
(885)
(933)
(1 182)
(975)
(1 074)
(729)
(814)
(847)
(892)
(884)
(854)
Gross Profit
557
N/A
591
+6%
618
+4%
657
+6%
675
+3%
1 025
+52%
690
-33%
956
+39%
561
-41%
568
+1%
742
+31%
621
-16%
775
+25%
539
-30%
586
+9%
620
+6%
671
+8%
693
+3%
679
-2%
Operating Income
Operating Expenses
(331)
(331)
(338)
(333)
(336)
(519)
(387)
(514)
(397)
(355)
(457)
(375)
(434)
(270)
(309)
(309)
(304)
(260)
(265)
Selling, General & Administrative
(333)
(333)
(340)
(336)
(341)
(531)
(402)
(592)
(408)
(400)
(508)
(400)
(459)
(298)
(328)
(332)
(335)
(324)
(328)
Research & Development
0
0
0
0
0
0
0
0
0
0
(3)
0
0
0
0
0
0
0
0
Other Operating Expenses
2
1
2
3
6
12
15
79
11
45
55
26
24
28
19
23
31
64
63
Operating Income
226
N/A
260
+15%
280
+8%
324
+16%
339
+5%
507
+49%
303
-40%
442
+46%
164
-63%
213
+30%
284
+34%
246
-14%
341
+39%
269
-21%
277
+3%
311
+12%
367
+18%
433
+18%
414
-4%
Pre-Tax Income
Interest Income Expense
(8)
(17)
(29)
(45)
(35)
(53)
(48)
(60)
(35)
(27)
11
(15)
(22)
(45)
(57)
(58)
(54)
(56)
(41)
Non-Reccuring Items
3
1
0
(0)
5
13
8
9
91
8
0
0
22
26
6
2
(2)
(3)
(2)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
Total Other Income
0
0
0
0
0
0
0
0
0
0
(38)
0
(5)
0
0
0
0
0
0
Pre-Tax Income
221
N/A
244
+10%
251
+3%
280
+11%
309
+11%
467
+51%
263
-44%
391
+49%
221
-44%
195
-12%
259
+33%
231
-11%
337
+46%
250
-26%
226
-10%
255
+12%
311
+22%
374
+20%
372
0%
Net Income
Tax Provision
(40)
(39)
(46)
(54)
(56)
(83)
(46)
(61)
(34)
(38)
(50)
(44)
(61)
(43)
(41)
(44)
(58)
(73)
(69)
Income from Continuing Operations
181
205
205
225
254
383
217
330
186
157
209
188
276
207
186
210
253
301
303
Income to Minority Interest
(2)
(2)
(3)
(6)
(8)
(13)
(3)
(13)
(13)
(5)
461
(10)
448
0
11
0
0
0
0
Net Income (Common)
179
N/A
203
+13%
202
0%
219
+9%
251
+14%
378
+51%
216
-43%
318
+48%
174
-45%
151
-13%
209
+38%
178
-15%
234
+32%
251
+7%
269
+7%
267
-1%
253
-5%
301
+19%
303
+1%
EPS (Diluted)
0.11
N/A
0.11
N/A
0.11
N/A
0.12
+9%
0.13
+8%
0.19
+46%
0.11
-42%
0.16
+45%
0.09
-44%
0.08
-11%
0.1
+25%
0.09
-10%
0.13
+44%
0.13
N/A
0.14
+8%
0.13
-7%
0.13
N/A
0.15
+15%
0.15
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett